211 related articles for article (PubMed ID: 16832410)
1. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer.
Radke I; Götte M; Kersting C; Mattsson B; Kiesel L; Wülfing P
Br J Cancer; 2006 Aug; 95(3):347-54. PubMed ID: 16832410
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.
Hao RT; Zhang XH; Pan YF; Liu HG; Xiang YQ; Wan L; Wu XL
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1349-57. PubMed ID: 20140626
[TBL] [Abstract][Full Text] [Related]
3. Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma.
Liu YQ; Li HX; Lou X; Lei JY
Arch Pathol Lab Med; 2008 Aug; 132(8):1307-12. PubMed ID: 18684031
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.
Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ
Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324
[TBL] [Abstract][Full Text] [Related]
5. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
[TBL] [Abstract][Full Text] [Related]
6. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.
Miskad UA; Semba S; Kato H; Yokozaki H
Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer.
Ustaalioglu BB; Bilici A; Barisik NO; Aliustaoglu M; Vardar FA; Yilmaz BE; Seker M; Gumus M
Clin Transl Oncol; 2012 Dec; 14(12):911-22. PubMed ID: 22855168
[TBL] [Abstract][Full Text] [Related]
8. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
9. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
10. Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma.
Patel NA; Patel PS; Vora HH
Breast Dis; 2015; 35(2):113-27. PubMed ID: 25547164
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
Reich R; Hadar S; Davidson B
Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
[TBL] [Abstract][Full Text] [Related]
12. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.
Mayinuer A; Yasen M; Mogushi K; Obulhasim G; Xieraili M; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
Ann Surg Oncol; 2013 Jan; 20(1):305-17. PubMed ID: 23064776
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
[TBL] [Abstract][Full Text] [Related]
15. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
17. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
18. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
[TBL] [Abstract][Full Text] [Related]
20. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]